CPN1 and obesity due to melanocortin 4 receptor deficiency: Thus, this study was designed to screen and unveil the key targets and pathways of Cpn in alleviating obesity in mice by utilizing an integrated strategy that combined network pharmacology, quantitative transcriptomics, molecular docking, and experimental validation.